Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,502
Closed -$208K 887
2024
Q3
$208K Sell
7,502
-12,572
-63% -$357K ﹤0.01% 877
2024
Q2
$555K Buy
20,074
+2,222
+12% +$73.5K ﹤0.01% 825
2024
Q1
$686K Buy
17,852
+11,071
+163% +$369K ﹤0.01% 725
2023
Q4
$207K Buy
+6,781
New +$200K ﹤0.01% 939
2023
Q1
Sell
-14,192
Closed -$336K 1027
2022
Q4
$336K Buy
+14,192
New +$319K ﹤0.01% 965

Other funds holding NX

Aviva's NX Position: Q4 2024 in Review

Aviva sold out of Quanex (NX) in Q4 2024, closing a stake of 7,502 shares — an estimated $208K sold.

Aviva first reported a position in NX in Q4 2022 and held it in 5 quarters. The position peaked at $686K in Q1 2024. 196 funds tracked by Wall St. Rank hold NX as of Q4 2024.

  • Aviva reported no remaining Quanex position as of Q4 2024 after selling out during the quarter.
  • Aviva sold 7,502 Quanex shares in Q4 2024, an estimated $208K.
  • Aviva first reported a position in Quanex in Q4 2022 and held it in 5 quarters.
  • Aviva's Quanex position peaked at $686K in Q1 2024.
  • 196 funds tracked by Wall St. Rank held Quanex as of Q4 2024.

Based on Aviva's 13F filing for Q4 2024, filed 13 Feb 2025.